Further studies demonstrate that miR-1 prevents cardiac hypertrophy by suppressing heart and neural crest derivatives expressed 2 (Hand2), and by inhibiting the activity of insulin-like growth factor (Igf1) and extracellular matrix remodeling factor, twinfilin 1 (Twf1) [10,11]. The gene discussed is TWF1; the disease is cardiac hypertrophy.